| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.013 | 0.9 |